- Addition of dordaviprone strengthens Jazz's late-stage oncology pipeline and reinforces commitment

Investing in biotech can be highly rewarding but is fraught with risks; understanding past catalysts

New Drug Application (NDA) for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

DURHAM, N.C., March 07, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on Mar

NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is inves

Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals are included in this Anal

CMRX and JAZZ are in the spotlight this week following an acquisition agreement.

JAZZ's acquisition of CMRX is set to add a rare high-grade brain tumor drug currently under the FDA'

NEW YORK , March 5, 2025 /PRNewswire/ -- Monteverde & Associates PC  (the "M&A Class Action Firm"),

NEW YORK , March 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investiga

On Tuesday, Jazz Pharmaceuticals plc JAZZ agreed to acquire Chimerix Inc CMRX for $8.55 per share in

Jazz Pharmaceuticals will acquire biotech firm Chimerix for about $935 million to gain access to its

-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tu

-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tu

The company holds potential to have first approval of dordaviprone for the treatment of recurrent H3

Chimerix (CMRX) made it through our "Recent Price Strength" screen and could be a great choice for i

DURHAM, N.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on Febr

Chimerix stock surges 324% in three months following NDA submission for high-grade glioma drug, dord

DURHAM, N.C., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

  During Tuesday's trading, 188 companies set new 52-week lows.

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

  During Wednesday's session, 117 stocks hit new 52-week lows.

  On Tuesday, 164 companies hit new 52-week lows.

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

  On Thursday, 185 companies achieved new lows for the year.

  On Wednesday, 345 companies set new 52-week lows.

  Tuesday's session saw 286 companies set new 52-week lows.

  On Wednesday, 81 companies hit new 52-week lows.

  On Friday, 469 companies hit new 52-week lows.

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and

Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin

Gainers

  Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings fo

  On Tuesday, 951 companies hit new 52-week lows.

  During Monday's trading, 1214 companies set new 52-week lows.

US stock futures traded higher this morning on Monday. Investors, meanwhile, focused on some notable

  On Monday, 198 companies reached new 52-week lows.

  Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e

  Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report q

  Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly e

  Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings